|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61K 31/506 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3110444 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15708638.0 |
| Europos patento paraiškos padavimo data | 2015-02-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-01-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-01-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/016529 |
| Data | 2015-02-19 |
| (87) | Numeris | WO 2015/130540 |
| Data | 2015-09-03 |
| (30) | Numeris | Data | Šalis |
| 201461944811 P | 2014-02-26 | US |
| (72) |
CHAN, Edward Michael, US
|
| (73) |
Eli Lilly and Company,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | COMBINATION THERAPY FOR CANCER |
| COMBINATION THERAPY FOR CANCER |